Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 18 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 10 |
GO:0110165 | cellular anatomical entity | 1 | 10 |
GO:0018995 | host cellular component | 2 | 1 |
GO:0033643 | host cell part | 3 | 1 |
GO:0033644 | host cell membrane | 4 | 1 |
Related structures:
AlphaFold database: Q4QHA5
Term | Name | Level | Count |
---|---|---|---|
GO:0016032 | viral process | 1 | 1 |
GO:0019042 | viral latency | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.602 |
CLV_PCSK_PC1ET2_1 | 45 | 47 | PF00082 | 0.632 |
CLV_PCSK_SKI1_1 | 151 | 155 | PF00082 | 0.337 |
CLV_PCSK_SKI1_1 | 158 | 162 | PF00082 | 0.362 |
DEG_Nend_UBRbox_3 | 1 | 3 | PF02207 | 0.616 |
DOC_MAPK_MEF2A_6 | 77 | 84 | PF00069 | 0.557 |
DOC_MAPK_RevD_3 | 32 | 46 | PF00069 | 0.420 |
DOC_PP1_RVXF_1 | 149 | 156 | PF00149 | 0.534 |
DOC_USP7_UBL2_3 | 10 | 14 | PF12436 | 0.584 |
DOC_USP7_UBL2_3 | 117 | 121 | PF12436 | 0.452 |
LIG_14-3-3_CanoR_1 | 151 | 156 | PF00244 | 0.551 |
LIG_14-3-3_CanoR_1 | 20 | 26 | PF00244 | 0.558 |
LIG_FHA_1 | 22 | 28 | PF00498 | 0.329 |
LIG_FHA_1 | 37 | 43 | PF00498 | 0.277 |
LIG_FHA_1 | 66 | 72 | PF00498 | 0.420 |
LIG_FHA_2 | 129 | 135 | PF00498 | 0.348 |
LIG_FHA_2 | 152 | 158 | PF00498 | 0.562 |
LIG_PCNA_yPIPBox_3 | 149 | 158 | PF02747 | 0.540 |
LIG_SH2_STAP1 | 86 | 90 | PF00017 | 0.346 |
LIG_SH2_STAT3 | 86 | 89 | PF00017 | 0.464 |
LIG_SUMO_SIM_par_1 | 134 | 140 | PF11976 | 0.427 |
LIG_SUMO_SIM_par_1 | 24 | 29 | PF11976 | 0.346 |
LIG_SUMO_SIM_par_1 | 34 | 39 | PF11976 | 0.289 |
LIG_SUMO_SIM_par_1 | 63 | 68 | PF11976 | 0.380 |
LIG_UBA3_1 | 160 | 165 | PF00899 | 0.467 |
LIG_WRC_WIRS_1 | 152 | 157 | PF05994 | 0.440 |
MOD_CK1_1 | 99 | 105 | PF00069 | 0.394 |
MOD_CK2_1 | 128 | 134 | PF00069 | 0.437 |
MOD_GSK3_1 | 119 | 126 | PF00069 | 0.503 |
MOD_GSK3_1 | 36 | 43 | PF00069 | 0.302 |
MOD_GSK3_1 | 65 | 72 | PF00069 | 0.380 |
MOD_GSK3_1 | 92 | 99 | PF00069 | 0.391 |
MOD_N-GLC_1 | 21 | 26 | PF02516 | 0.399 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.490 |
MOD_NEK2_1 | 16 | 21 | PF00069 | 0.454 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.150 |
MOD_NEK2_1 | 65 | 70 | PF00069 | 0.427 |
MOD_NEK2_1 | 96 | 101 | PF00069 | 0.321 |
MOD_NEK2_2 | 40 | 45 | PF00069 | 0.504 |
MOD_PIKK_1 | 119 | 125 | PF00454 | 0.479 |
MOD_PIKK_1 | 145 | 151 | PF00454 | 0.368 |
MOD_PIKK_1 | 171 | 177 | PF00454 | 0.595 |
MOD_PKA_2 | 80 | 86 | PF00069 | 0.427 |
MOD_Plk_1 | 21 | 27 | PF00069 | 0.324 |
MOD_Plk_4 | 137 | 143 | PF00069 | 0.459 |
MOD_Plk_4 | 151 | 157 | PF00069 | 0.371 |
MOD_Plk_4 | 69 | 75 | PF00069 | 0.293 |
MOD_Plk_4 | 80 | 86 | PF00069 | 0.346 |
MOD_Plk_4 | 92 | 98 | PF00069 | 0.387 |
MOD_SUMO_for_1 | 44 | 47 | PF00179 | 0.535 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HX82 | Leptomonas seymouri | 76% | 100% |
A0A0S4INN4 | Bodo saltans | 42% | 99% |
A0A1X0NQE8 | Trypanosomatidae | 60% | 100% |
A0A3R7KZM5 | Trypanosoma rangeli | 59% | 100% |
A0A3S7WRC6 | Leishmania donovani | 97% | 100% |
A4H697 | Leishmania braziliensis | 86% | 100% |
A4HUM1 | Leishmania infantum | 97% | 100% |
C9ZVP8 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 24% | 100% |
E9ANB9 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 95% | 100% |